glp-1 cardiovascular benefits news The Big Trial of a drug (Wegovy) to Reduce Major Events Stopping GLP-1s Increases Risk of – GLP-1 Agonists in Cardiovascular Diseases:

Helmholtz Munich ist ein biomedizinisches Spitzenforschungszentrum und Teil von Helmholtz Health, einem europaweit einmaligen Verbund, der Lsungen fr eine gesndere Gesellschaft entwickelt

BPC-157 stimulates fibroblasts, the cells responsible for producing collagen, while also influencing how new collagen fibers align

Detailed Description BPC-157 , also known as Body Protection Compound-157, is a synthetic pentadecapeptide (15 amino acids) derived from a naturally occurring protein in gastric juice

doi:10.3109/15563659309000395

I am not a doctor but a 25 year Lyme patient who wasnt diagnosed until Id had it 9 years